Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) have been given a consensus rating of “Hold” by the fourteen ratings firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy […]
Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective decreased by Truist Financial from $137.00 to $130.00 in a research report released on Friday morning, Benzinga reports. Truist Financial currently has a hold rating on the medical equipment provider’s stock. ZBH has been the topic of a number of other research reports. JPMorgan Chase […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) issued its quarterly earnings data on Thursday. The medical equipment provider reported $1.94 EPS for the quarter, topping the consensus estimate of $1.87 by $0.07, RTT News reports. Zimmer Biomet had a net margin of 12.93% and a return on equity of 12.70%. The business had revenue of […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $8.00-8.15 for the period, compared to the consensus estimate of $8.06. The company issued revenue guidance of $7.73-7.80 billion, compared to the consensus revenue estimate of $7.75 billion. […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $8.00-8.15 for the period, compared to the consensus EPS estimate of $8.06. The company issued revenue guidance of $7.73-7.80 billion, compared to the consensus revenue estimate of $7.75 billion. Analyst Ratings Changes A number of […]